Lake Forest, CA, Release: June 14, 2022 The global research-based life science company, Invitrx Therapeutics is now collaborating with the Stem Cell and Regenerative Medicine Research Center of IUMS, the highest-ranked medical university in Iran. With a joint effort, we […]
Invitrx Therapeutics is excited to have the opportunity to unveil our science-based skincare brand, Reluma, at this very grand show in Italy. Stemming from the homologous technology for burns and open wounds, the core active, Polypeptide Enriched Media, is clinically demonstrated […]
Effects of Test Items in the Carrageenan Paw Edema Model in Rat, an Animal Study sponsored by Invitrx Therapeutics with Charles River Laboratories as testing facility was conducted on December 2020 to study Cord Blood Stem Cells (CBSC) as an anti-inflammatory product. The research was concluded in January 2021.
Your body is the most important part of staying healthy and beautiful. I basically recommend people a healthy diet, exercise, good sleeping
Invitrx Therapeutics has formally signed a joint venture agreement with Baylx, Inc. (Baylx), to co-sponsor Baylx’s FDA approved Investigational
Invitrx Therapeutics, headquartered in Irvine, California, is a global research-based life science company with more than 10 years of experience